The criticism is frequently made that metabolic diseases such as those related to the parathyroid glands require for their successful treatment laboratory facilities beyond the reach of all but a very few. It is my object in this note to point out that this is no longer true as regards hypoparathyroidism.
It is perhaps of interest that in hypoparathyroidism and diabetes mellitus there is quite close parallelism as regards the evolution of therapeutics. In both conditions there was a time when the treatment required a great deal of scientific knowledge and laboratory equipment and was none too satisfactory; now the treatment is both simple and satisfactory. Insulin and especially protamine zinc insulin made the difference with diabetes; dihydrotachysterol with hypoparathyroidism. From an academic point of view it is perhaps too bad that the practitioner no longer needs to master ketogenic-antiketognic ratios or the interesting detailed knowledge on the treatment of
ALBRIGHT F. NOTE ON THE MANAGEMENT OF HYPOPARATHYROIDISM WITH DIHYDROTACHYSTEROL. JAMA. 1939;112(25):2592–2593. doi:10.1001/jama.1939.02800250016006
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: